Latest News about NVO
Recent news which mentions NVO
From MarketWatch
Walmart seems to have changed its view of weight-loss drugs
December 06, 2023
From MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
From Benzinga
Obesity Drugs: Greater Weight Loss Linked to Prolonged Use of Novo Nordisk's Wegovy
December 06, 2023
Tickers
NVO
From Benzinga
Goldman Sachs money manager digs into three themes for long-term growth
December 05, 2023
From MarketWatch
No more exercising? President RFK Jr.? Here’s one bank’s outrageous predictions for 2024
December 05, 2023
From MarketWatch
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
From Benzinga
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
December 04, 2023
From Benzinga
From Benzinga
1 Stock-Split Stock to Buy Hand Over Fist in December, and 1 to Avoid Like the Plague
December 04, 2023
From Motley Fool
3 No-Brainer Growth Stocks to Buy in December
December 03, 2023
From Motley Fool
Everyone Is Talking About This Stock. Is It a Good Long-Term Option?
December 02, 2023
Tickers
NVO
From Motley Fool
An Important History Lesson for Gene-Editing Investors
December 02, 2023
From Motley Fool
Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?
December 02, 2023
From Motley Fool
Advocacy for Wegovy: Denmark Signals Cost-Sharing Talks While Novo Spent Millions On Medical Community For Drug Promotion
December 01, 2023
Tickers
NVO
From Benzinga
Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
December 01, 2023
From Benzinga
Weight Loss Drugs - Novo Nordisk A Primary Beneficiary In Obesity Space Currently Controlled By Two Players, Says Analyst
December 01, 2023
From Benzinga
Will Novo Nordisk Be a Trillion-Dollar Stock by 2030?
December 01, 2023
Tickers
NVO
From Motley Fool
From MarketWatch
Novo Nordisk Sues Florida Compounding Pharmacies Over Impurities In Products Claiming To Contain Wegovy Ingredient
November 30, 2023
From Benzinga
From Motley Fool
Counterfeit Ozempic Raises Alarms - Lebanon Reports Hypoglycemia Cases
November 29, 2023
From Benzinga
UnitedHealth forecasts 2024 revenues that top expectations
November 29, 2023
From MarketWatch
From Motley Fool
Eli Lilly's Blockbuster Mounjaro Shows Larger, Faster Weight Loss Than Novo Nordisk's Ozempic In Real World Study
November 28, 2023
From Benzinga
Only Have $100? 3 No-Brainer Stocks to Buy Right Now
November 28, 2023
From InvestorPlace
Novo Nordisk's Flexible Pricing Approach: Push for Broader Access, Innovative Payments
November 27, 2023
From Benzinga
Eli Lilly’s Mounjaro three times more effective than Ozempic for weight loss, real-world study finds
November 27, 2023
From MarketWatch
From Motley Fool
Could Ozempic Harm These 3 Medical Device Stocks?
November 25, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.